CanniMed Therapeutics Inc. (TSE:CMED – Get Free Report) dropped 5.3% on Monday . The company traded as low as C$27.00 and last traded at C$27.00. Approximately 52,208 shares traded hands during mid-day trading, a decline of 87% from the average daily volume of 387,394 shares. The stock had previously closed at C$28.50.
CanniMed Therapeutics Stock Down 5.3 %
About CanniMed Therapeutics
CanniMed Therapeutics Inc operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills.
See Also
- Five stocks we like better than CanniMed Therapeutics
- What Are Dividend Challengers?
- Buffett Bails on BYD: What It Means for the Future of EV Stocks
- Industrial Products Stocks Investing
- Domino’s vs. Papa John’s: Stock Showdown of Pizza Giants
- Most active stocks: Dollar volume vs share volume
- Williams-Sonoma Makes Stock More Accessible with a Stock Split
Receive News & Ratings for CanniMed Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanniMed Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
